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Ultrastructural organization of hemodialysis-associated fi2-micro-
globulin amyloid fibrils. Fibrils of hemodialysis-associated 32-microglobu-
un amyloid were examined by high resolution electron microscopy and
immunohistochemical labeling. The amyloid containing tissues obtained
through autopsy were prepared for thin section observations. In contrast
to other forms of amyloid, the most conspicuous feature of these fibrils
were their curved conformations. The fibril core showed ultrastructural
and immunohistochemical features in common with the core of connective
tissue microfibrils and of previously observed fibrils of experimental
murine AA amyloidosis and familial amyloid polyneuropathy (FAP). The
core was wrapped in a layer of 3 nm wide ribbon-like "double tracked"
structures identified as chondroitin sulfate proteoglycan (CSPG) with
immunogold labeling as well as from the results of previous in Vitro
experiments. Finally, the outer surface of the fibril was associated with a
loose assembly of I nm wide filaments immunohistochemically identified
as 2-microglobulin. This is similar to the manner in which AA protein and
transthyretin filaments are associated with their respective fibrils. The
results of this study provide an additional example for the concept that
amyloid fibrils in general are microfibril-like structures externally associ-
ated with amyloid protein filaments. An unusual feature of the fibrils of
hemodialysis-associated amyloid, however, is the presence of a peripheral
layer composed of CSPG rather than of heparan sulfate proteoglycan
(HSPG) as in the case of the other two amyloids above. These chondroitin
sulfate chains in the Outer CSPG layer may be less effective in providing
rigidity to the fibril core, thus allowing for the curved conformations of
J32-microglobulin amyloid fibrils.
Amyloidosis following on chronic hemodialysis is a relatively
new disease, having been first described about 12 to 15 years ago
[1—41. The failure to see this disorder prior to these dates rests on
the necessity for long-term survival in the presence of renal
failure, a condition that was not met until hemodialysis became
common and allowed such patients to live for periods in excess of
10 to 15 years. Over this period of time the majority of renal
patients develop a distinctive amyloid arthropathy that may affect
most major joints such as the spine, hips, knees, shoulders and
periarticular tissues [5]. Involvement of the gastrointestinal tract
also occurs [61, indicating that this process is systemic and not
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restricted to the bones and joints. The specific protein associated
with these amyloid deposits is 32-microglobulin [1—41.
f32-microglobulin is a component of the major histocompatihil-
ity loci of cells and a normal serum protein of a small size (Mr
11,731) [7). This protein is known to accumulate in the blood of
patients undergoing long-term hemodialysis to levels S to 10 times
normal because of the inability of this procedure to remove the
protein from the blood plasma [8, 91.
This amyloid is ultrastructurally composed of deposits of fibrils
as in other types of amyloid. However, the fibrils of this particular
type of amyloid are unique in that they show an unusually atypical
"curvilinear" conformation in contrast to straight fibrils in most
other amyloids [2, 10, 111. Fibrils of 132-microglobulin can form
spontaneously in vitro in the supernatant of cultures of mononu-
clear cells from dialysis patients apparently from intact precursor
protein molecules rather than from the product of proteolytic
transformation [12, 131. These fibrils formed in vitro were approx-
imately 8 to 10 nm in thickness again with curved appearances.
In spite of these electron microscopic observations, the detailed
ultrastructural organization of the fibrils of hemodialysis-associ-
ated amyloid is not clear. Our recent detailed high resolution
observations have shown that the fibrils of both experimental
murine AA amyloid [14) and FAP [Inoue et al, manuscript in
preparation) resembled microfibril-like structures, and the pro-
teins specific to these amyloids, AA protein and transthyretin,
respectively, were immunohistochemically identified as 1 to 2 nm
wide flexible filaments associated with the surface of the fibril.
Microfibrils are unbranching rod-like structures approximately
10 nm in width. They are one of the major components of the
connective tissue either in association with elastic fibers [51 or
free in the tissue space such as, for example, those composing a
suspensory ligament (zonular fibers) in the eye [161. Amyloid
fibrils in situ are also unbranching rods and resemble connective
tissue microfibrils in their size and appearance [17). Recent results
frcm our laboratories have shown that the 9 nm wide fibril core is
identical in microfibrils, and amyloid fibrils so far examined, and
it is composed of peripheral CSPG with a center of amyloid P
component (AP) [14, 18; lnoue et al, manuscript in preparation].
The difference between these two distinct types of fibrils relates to
their surfaces, which in the case of the microfibril is associated
with periodically distributed fibrillin and accumulations of HSPG
[191, while in the case of amyloid fibril the core is associated with
a layer of HSPG accompanied on its surface by I nm wide
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filaments composed of an amyloid protein [14; Inoue et al,
manuscript in preparation].
In this study the ultrastructure of the fibrils of hemodialysis-
associated amyloid was examined with high resolution electron
microscopy in combination with immunohistochemical labeling to
determine whether they are also microfibril-like in nature resem-
bling the previous two described forms of amyloid.
METHODS
Ultrastructure
Hemodialysis-associated /32-microglobulin amyloid tissue was
obtained through autopsy from a 73-year-old male patient with
chronic glomerulonephritis. Pieces of the tissue were fixed with
2.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.2, for two
hours at room temperature. They were washed with the same
buffer and further cut into blocks approximately 1 mm3. The
blocks were postfixed with 1% osmium tetroxide in the same
buffer for one hour at 4°C and briefly rinsed with distilled water,
followed by dehydration and embedding in Epon. Thin sections
were stained with uranyl acetate followed by lead citrate before
examination in a Philips EM400 or JEM-2000FX electron micro-
scope. Magnification was calibrated with a grating replica and a
catalase crystal standard. Size was measured on prints with a hand
magnifier equipped with a 0.1 mm scale.
Immunolabeling
Thin sections of glutaraldehyde- and osmium tetroxide-fixed,
Epon-embedded tissue of 32-microg1obuIin amyloid prepared as
above were pre-treated with sodium metaperiodate (NaIO4)
according to the method of Bendayan and Zollinger [20] and then
labeled for f32-microglobulin or chondroitin sulfate with the
immunogold method similar to that used previously [14]. Thin
sections on nickel grids were exposed to a saturated aqueous
solution of Na104 for one hour. They were washed with distilled
water and then floated on the surface of a drop of 1% bovine
serum albumin (BSA) in phosphate buffered saline (PBS) fol-
lowed by a drop of (i) rabbit anti-human 132-microglobulin anti-
serum (dilution 1:100; DAKO Corporation, Carpinteria, CA,
USA) or (ii) monoclonal anti-mouse chondroitin sulfate anti-
serum (dilution 1:100; Sigma, St. Louis, MO, USA), for one hour
at room temperature. In the case of (ii), sections were pretreated
with 10% hydrogen peroxide immediately after the Na104 treat-
ment. Control sections were exposed to non-immune rabbit serum
or non-immune mouse serum. The grids were washed by passing
them sequentially across three wells filled with PBS and then a set
of drops of PBS containing 1% BSA. They were then floated on
the surface of drops of 0.05 M Tris-HCI buffer, pH 7.6, and
exposed to goat anti-rabbit or anti-mouse immunoglobulins cou-
pled to 5 nm gold particles (dilution 1:15; Janssen Pharmaceutica,
Antwerp, Belgium) for 30 minutes at room temperature. The
grids were washed by first placing them on drops of Tris-HCI
buffer, then in a gentle stream of the same solution followed by
distilled water. Finally, the sections were counterstained with
uranyl acetate and lead citrate for four minutes and 15 seconds,
respectively, before examination in the electron microscope. For
assessment of the extent of the labeling the number of gold
particles per II m2 square of the sections that were associated
with 1 nm wide filaments (after labeling for 132-microglobulin), or
with 3 nm wide ribbon-like "double tracks" (after labeling for
chondroitin sulfate) in both experimental and control sections
were enumerated. The numbers averaged from five randomly
selected squares in each specimen was used for quantitative
evaluation of the labeling.
RESULTS
Ultrastructure of j32-microglobulin amyloid fibrils
Amyloid fibrils were mainly localized to the space between
collagen fibrils as aggregates of various sizes (Fig. 1A). The most
conspicuous feature of these fibrils was their intense curving with
a twisted appearance, contrasting with the fibrils of AA [14] and
FAP amyloid [Inoue et a!, manuscript in preparation], which were
either straight or only gently curved. Therefore, in thin sectioned
tissues mainly short and curved fibril segments of approximately
12 nm in width were observed (Fig. 1A). These intensely curved
fibrils, unable to form bundles, accumulated as loose random
assemblies. At a higher magnification only segments of limited
lengths of variously curved fibrils were seen, and their contours
were irregular and indistinct (Fig. 1B, bold arrow).
The fibrils in which the plane of section passed at various levels
from the surface to the interior were examined at high magnifi-
cation. Each successive level was identified by examining sections
cut slightly oblique to the axis of the fibril so that the transition
from one level to the next could be seen. The space immediately
above and close to the surface of curved short segments of
individual fibrils was examined first (Fig. 2A). The surface was
associated with flexible filaments approximately I nm in thickness.
When fibrils were sectioned at a level of or slightly below the
surface (Fig. 2B) this peripheral part of the fibril was found to be
composed of a random assembly of ribbon-like "double tracked"
structures. They were composed of two parallel dark lines sepa-
rated by a lucent space. They were also associated on both sides
with variable amounts of darkly stained material. The width of
these characteristic ribbons was 3.0 0.2 nm (N 50; Fig. 3A).
At a level of deeper sectioning of the fibril, the contour of the core
of the fibril, 8 to 9 nm in width, begins to emerge (Fig. 2C). A
characteristic feature of the surface of the core is the presence of
cross striations. The pattern of cross striations was resolved into a
series of double tracked structures (Fig. 2C, paired arrows). The
width of these double tracked structures is 3.0 0.2 nm (N = 20)
(Fig. 3B). They were indistinguishable in detailed appearance
from those composing the peripheral layer of the fibril. In Figure
2C the short segment of the fibril is curved within the plane
perpendicular to the surface of the section. Because of the
curvature the lower three double tracks are tilted slightly away
from the face-on view, showing their side view with darkly stained
material associated at their sides (single medium arrows).
The core was also sectioned both transversely (Fig. 4B) and
longitudinally through its center (Fig. 4 A, C, D). In longitudinal
sections the core, approximately 9 nm in diameter, is composed of
three parallel lines in which the middle one is often seen as being
composed of a series of dark dots (Fig. 4A). The core is often bent
sharply (Fig. 4C) or more gently (Fig. 4D). In cross section one of
the dots composing the middle line is present at the center of a
pentagonal frame approximately 9 nm in width (Fig. 4B).
Immunolocalization of 2-microglobulin and chondroitin
sulfate
After immunolabeling for J32-microglobulin 5 nm gold particles
were associated with 1 nm wide filaments at the surface of the
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Fig. 1. Deposit of hemodialysis-associated j2-microgIobulin amyloid. (A) A large accumulation of amyloid fibrils (AF) is present among collagen fibrils(Col). Examples of short segments of intensely curved fibrils are indicated by arrows. (B) Higher power view of a part of A. The same short segment
of a curved fibril indicated by an arrow at the upper center in A is shown at a bold arrow (A X86,700; B x295,800).
fibrils (Fig. 5A). At high magnification it was confirmed that the
particles were preferentially associated with I nm wide filaments,
and none of the other structures in the fibrils were labeled (Fig.
SB). The number, averaged from five different areas, of gold
particles associated with 1 nm wide filaments was 425.4/jim2 while
in control sections average number of particles associated with the
filaments was 4.4/jim2. After labeling for chondroitin sulfate gold
particles were preferentially associated with 3 nm wide double
tracked structures, which were composed either the surface layer
of the fibril (Fig. 6 A, B, C) or the peripheral component of the
fibril core (Fig. 6D). The number of gold particles associated with
3 nm wide "double tracks" averaged from five different areas, was
34.6/jim2 and 2.6/jim2 in experimental and control sections,
respectively.
DISCUSSION
Until 25 to 30 years ago, because of its unique tinctorial,
ultrastructural, and conformational features, amyloid was thought
to be a single entity regardless of its tissue localization or clinical
context. The advent of techniques to isolate amyloid fibrils [21],
quickly led to the realization that there were many forms of
amyloid. Each was composed of a unique protein that was
characteristic of the antecedent clinical condition. At least 17
different amyloid proteins have now been identified, and these
now serve as the basis for classifying amyloids [22], rather than the
clinical setting that was used previously.
In many cases the pure amyloid protein can, under prompting
from non-physiologic in vitro conditions, be urged to aggregate
into fibrils. This has led to the concept that fibrillogenesis requires
only the amyloid protein. Nevertheless, additional common amy-
bid components, such as AP and HSPG, have been identified in
situ irrespective of the type of amyloid. In some cases these
components have been clearly implicated in the process of
fibrillogenesis [23—28]. How these additional components are
involved in amyloid structure is only now beginning to emerge [14,
25].
The fact that there are significant differences between the
reported ultrastructure of isolated amyloid fibrils [29—32] and
those of fibrils in situ [33—36] also indicates that the ultrastructural
organization and biochemical composition of amyloid fibrils are
not as simple as previously believed.
In a recent high resolution ultrastructural study [14] the fibrils
of experimental murine AA amyloid were shown to be microfibril-
like structures. The cores of both AA amyboid fibrils and connec-
tive tissue microfibrils [18] are composed of helically wound 3 nm
wide ribbon-like CSPG "double tracks" that enclose AP at their
center. The cores of both AA amyloid fibrils and microfibrils [19]
are covered by a layer of HSPG. In the ease of AA amyloid a loose
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Fig. 2. Ultrastructural organization of the fibril of 2-microglobulin amyloid as seen in single fibrils. Approximate length of the segments of curved
fibrils which span the thickness of the section is indicated between opposed bold arrows. (A) Flexible filaments 1 nm in width (small arrows) are
associated with the surface of the fibril. (B) Peripheral layer of the fibril is composed of random assemblies of 3 nm wide double tracks (paired arrows).(C) The surface of the fibril core. Cross striations made up of 3 nm wide double tracks (paired arrows) are present. Some of them are slightly tilted
because of the curvature of the segment and show their side view (single arrows) (A X557,600; B X634,100; C X676,600).
network of fine filaments, immunohistochemically identified as
AA protein, was localized on the surface of the HSPG [14]. A
similar organization was shown for the fibrils of familial amyloi-
dotic polyneuropathy where the outermost surface of the micro-
fibril-like structure was associated with a loose network of fine
filaments immunohistochemically identified as transthyretin [In-
oue et al, manuscript in preparation]. Unpublished work [Inoue
and Kisilevsky] has revealed a similar organization for in situ
fibrils of AL and A amyloids as well. Therefore, it is possible that
amyloid fibrils in general may be microfibril-like in structure and
protein specific to each type of amyloid present in the form of fine
filaments associated at the surface of the fibrils. In this study fibrils
of an additional type of amyloid, hemodialysis-associated /32-
microglobulin amyloid, were examined at high resolution.
The cores of microfibrils [18] as well as the fibrils of experimen-
tal murine AA amyloid [14] and FAP [Inoue et al, manuscript in
preparation] were shown to be composed of helically arranged 3
nm wide CSPG double tracks enclosing AP at the center. The
detailed ultrastructural feature of the /32-microglobulin fibril core
of dialysis associated amyloid, (illustrated in Fig. 2C and Fig.
4A-D), is identical to that seen in microfibrils and the fibrils of
above two types of amyloid. Also, 3 nm wide double tracked
structures at the periphery of the core were immunolaheled for
chondroitin sulfate, Together with the fact that they closely
resembled, in size and detailed appearance, the double tracked
structures reconstituted in vitro after incubation of a CSPG
preparation at body temperature [18], it is likely that these 3 nm
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Fig. 3. Width of ribbon.like double tracked structures. (A) Double tracks
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Fig. 4. The core of amyloid fibrils sectioned transversely or longitudi-
nally. (A) The core longitudinally sectioned through the center is com-
posed of three parallel lines (sets of three arrows) in which the middle one
is made up of a series of successive dots. The core is often curved either
sharply (C) or more gently (D). Transverse section of the core shows a
pentagonal frame with a lumen containing a central dot (B, circled) (A, C
and D X574,100; B x559,100).
wide double tracked structures are composed of CSPG. In
summary, it is therefore likely that the f32-microglobulin fibril core
is also made up of helical CSPG double tracks with enclosed AP,
as schematically shown in Figure 7. In addition, the outermost
surface of the dialysis-associated amyloid fibril was found to be
associated with f32-microglobulin filaments. Thus, this study pro-
vides an additional example of amyloid fibrils that are microfibril-
like structures with a protein specific to the type of amyloid
present on the surface as a loose network of fine filaments.
There are, however, two unusual features in the fibril of
/32-microglobulin amyloid when compared with the fibrils of
experimental AA amyloid and of FAP. First, morphologically,
fibrils of f32-microglobulin amyloid are localized in the vicinity of
collagen fibrils that may be related to the known strong affinity of
this amyloid for collagen in Vitro [37, 38], and they are intensely
curved instead of being straight in accord with observations made
in previous reports [2, 10, 111. Second, the layer that encloses the
AP/CSPG fibril core is made up of random assemblies of 3 nm
wide double tracks immunolabeled for chondroitin sulfate and
ultrastructurally indistinguishable from double tracked structures
previously reconstituted in vitro from CSPG, and thus are likely to
be CSPG as discussed above. That is, the layer is made up of a
second CSPG layer instead of HSPG, which is the proteoglycan
layer seen in the other two types of amyloid. This latter finding is
in keeping with light microscopic analyses of 32-microg1obulin
amyloid where HSPG was shown to be present but as a minor
component relative to CSPG [39]. These two features may he
related to one another. Glycosaminoglycans (GAGs) containing
Fig. 5. linmunogold labeling of hemodialysis.associated amyloid for j2
microglobulin. (A) Five nm gold particles are present over and between
amyloid fibrils in association with 1 nm wide flexible filaments (arrows).
(B) High power view of the association of gold particles with the filaments
(thick arrows) (A ><361,800; B X581,600).
predominantly iduronic acid, such as heparan sulfate, are known
to have tighter binding properties as compared to GAGs, which
contain more glucuronic acid such as CSPG [40]. This difference
in GAG composition may be responsible for a more flexible, less
rigid, arrangement of fibril structure, and the more curved entities
seen in dialysis type amyloid than in AA and FAP.
Common tinctorial and structural characteristics of amyloids
include positive Congo red staining, which show red-green hire-
fringence under polarized light, the presence of cross structure
of amyloid proteins as detected by X-ray diffraction, and identi-
fication of approximately 10 nm wide fibrils at the electron
microscopic level. In the present study with /32-microglobulin
amyloid only the last feature was demonstrated. What elements of
our proposed structure is responsible for the other characterstics
is not clear at present. Since microfibrils themselves do not show
these staining and polarization charateristics, 132-microglobulin in
the form of the fine filaments at the surface of the fibril may be the
component that is related to these specific characteristics.
Preliminary observations in our laboratories (unpublished re-
sults) showed that the 1 nm wide filaments of AA protein in
experimental murine AA amyloid fibrils observed either in situ at
CSPG
CSPG
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Fig. 6. Immunogold labeling of hemodialysis-associated amyloid for chondroitin sulfate. (A-c) Gold particles are preferentially associated with 3 nm
wide "double tracks" (paired arrows) composing a surface layer of the fibril. (D) Three nm wide double tracks (paired arrows) composing a short
segment of the core of the fibril (bctween thick arrows) are attached by gold particles (A-D x649,400).
Fig. 7. Schematic drawing of ultrastructural
organization of f32-microglobulin amyloid fibril.
AP, subunits of amyloid P component; CSPG,
chondroitin sulfate proteoglycan in the form of
3 nm wide ribbon-like "double tracks"; /32-
microglobulin, I nm wide flexible filaments
containing 32-microglobulin. See text for a
detailed explanation.
the surface of the fibril or detached from it, had a tendency to coil
themselves to form 3 nm wide tight helices. In favorable areas of
AA amyloid tissues these helical rods were oriented parallel to the
direction of the fibril, and also to one another, with a regular
center-to-center distance of approximately 5 nm at the surface of
the fibril. If the arrangement of /32-microglobulin filaments is
similar to that of AA protein filaments, grooves 1.5 to 2 nm in
width between parallel helical rods at the surface of the fibril may
be a favorable site for attachment and orientation of molecules of
Congo red. Such an arrangement would be adequate for the
production of optical polarization. However, the cross-/3 confor-
mation of the amyloid protein is difficult to explain from the
results of this study.
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